乌鸦传媒

<乌鸦传媒 class="page-title">Clinical Challenges

ASH: DLBCL

<乌鸦传媒 class="page-description">American Society of Hematology

More in ASH: DLBCL

Clinical Challenges: Test Your Knowledge on Recent Advances in DLBCL

A three-question quiz covering our series on diffuse large B-cell lymphoma

Dec 26, 2023
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Secondary CNS Relapse in Diffuse Large B-Cell Lymphoma

Questions remain on how best to diagnose and treat CNS involvement in high-risk groups

Dec 26, 2023
ASH over a photo of San Diego Convention Center.
Clinical Challenges: Using Pola-R-CHP for Diffuse Large B-Cell Lymphoma

Regimen is approved for frontline treatment, but when it represents the best choice is less clear

Dec 18, 2023
ASH over a photo of San Diego Convention Center.
Clinical Challenges: CAR-T or Bispecifics in Relapsed/Refractory DLBCL

Patient preference, ease of administration, AEs may all weigh into treatment decisions

Dec 13, 2023
ASH over a photo of San Diego Convention Center.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis